Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
ABBOTT BIOTHERAPEUTICS CORP (FACT)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Dec-31-09 | Sep-30-09 | Jun-30-09 | Mar-31-09 | Dec-31-08 | Sep-30-08 | Jun-30-08 | Mar-31-08 |
| 8-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Research and development | 171.3% | 415.6% | 257.2% | 250.7% | 418.4% | 830.8% | 1875.7% | 966.2% |
General and administrative | 67.7% | 87.8% | 76.6% | 106.9% | 169.3% | 228.6% | 556.2% | 272.6% |
EBITDA | | | | -216.7% | -425.4% | | | -976.8% |
Depreciation | | | | 36.6% | 56.2% | | | 153.3% |
EBITA | -139.0% | -403.4% | -233.8% | -253.3% | -481.5% | -959.3% | -2331.9% | -1130.0% |
Amortization of intangibles | | | | 4.3% | 6.2% | | | 8.8% |
EBIT | -139.0% | -403.4% | -233.8% | -257.6% | -487.7% | -959.3% | -2331.9% | -1138.8% |
Pre-tax income | -196.2% | -387.5% | -387.2% | -303.9% | -751.5% | -987.8% | -2514.0% | -280.8% |
Income taxes | 7.3% | -10.3% | 0.0% | 0.0% | 0.1% | 0.3% | 1.6% | 0.6% |
Net income | -203.5% | -377.2% | -387.2% | -303.9% | -751.6% | -988.1% | -2515.6% | -281.4% |
|